- Home
- LCFY vs PRFX Comparison
LCFY vs PRFX Comparison
Compare LCFY & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- PRFX
- Stock Information
- Founded
- LCFY 2009
- PRFX 2007
- Country
- LCFY Australia
- PRFX Israel
- Employees
- LCFY N/A
- PRFX 6
- Industry
- LCFY
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- PRFX Health Care
- Exchange
- LCFY Nasdaq
- PRFX Nasdaq
- Market Cap
- LCFY 3.7M
- PRFX 2.9M
- IPO Year
- LCFY 2022
- PRFX 2020
- Fundamental
- Price
- LCFY $6.30
- PRFX $1.39
- Analyst Decision
- LCFY
- PRFX Hold
- Analyst Count
- LCFY 0
- PRFX 1
- Target Price
- LCFY N/A
- PRFX N/A
- AVG Volume (30 Days)
- LCFY 4.9M
- PRFX 185.0K
- Earning Date
- LCFY 07-07-2025
- PRFX 08-14-2025
- Dividend Yield
- LCFY N/A
- PRFX N/A
- EPS Growth
- LCFY N/A
- PRFX N/A
- EPS
- LCFY N/A
- PRFX N/A
- Revenue
- LCFY $2,668,385.00
- PRFX N/A
- Revenue This Year
- LCFY N/A
- PRFX N/A
- Revenue Next Year
- LCFY N/A
- PRFX N/A
- P/E Ratio
- LCFY N/A
- PRFX N/A
- Revenue Growth
- LCFY N/A
- PRFX N/A
- 52 Week Low
- LCFY $2.28
- PRFX $1.25
- 52 Week High
- LCFY $13.98
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- LCFY 63.49
- PRFX 33.95
- Support Level
- LCFY $2.51
- PRFX $1.25
- Resistance Level
- LCFY $13.98
- PRFX $1.76
- Average True Range (ATR)
- LCFY 0.91
- PRFX 0.10
- MACD
- LCFY 0.42
- PRFX -0.05
- Stochastic Oscillator
- LCFY 33.04
- PRFX 23.53
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.